Appeals court rules for FTC on HSR rulemaking on pharmaceuticals
A three-judge panel of the U.S. Court of Appeals for the District of Columbia Circuit ruled that the Federal Trade Commission was within its rights to write rules targeting a specific...To view the full article, register now.
Already a subscriber? Click here to view full article